Merck’s $8 Billion Cancer Vaccine Faces First US Jury Trial
Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine as safe, the latest high-stakes litigation for the pharmaceutical giant. Lawyers for a Los Angeles woman will argue Monday that …